T0	KEYPHRASE-NOTYPES 16 24	duration
T1	KEYPHRASE-NOTYPES 28 31	FNP
T2	KEYPHRASE-NOTYPES 37 39	LD
T3	KEYPHRASE-NOTYPES 76 88	causes
T4	KEYPHRASE-NOTYPES 92 106	peripheral FNP
T5	KEYPHRASE-NOTYPES 116 126	Resolution
T6	KEYPHRASE-NOTYPES 159 168	treatment
T7	KEYPHRASE-NOTYPES 174 191	overall prognosis
T8	KEYPHRASE-NOTYPES 231 247	several patients
T9	KEYPHRASE-NOTYPES 256 259	FNP
T10	KEYPHRASE-NOTYPES 268 279	many months
T11	KEYPHRASE-NOTYPES 291 314	intravenous ceftriaxone
T12	KEYPHRASE-NOTYPES 316 341	nThe laboratory diagnosis
T13	KEYPHRASE-NOTYPES 345 347	LD
T14	KEYPHRASE-NOTYPES 366 397	Erythrocyte sedimentation rates
T15	KEYPHRASE-NOTYPES 432 453	Cerebral spinal fluid
T16	KEYPHRASE-NOTYPES 455 458	CSF
T17	KEYPHRASE-NOTYPES 460 473	lymphocytosis
T18	KEYPHRASE-NOTYPES 478 499	elevated CSF proteins
T19	KEYPHRASE-NOTYPES 515 531	viral meningitis
T20	KEYPHRASE-NOTYPES 543 545	LD
T21	KEYPHRASE-NOTYPES 556 579	specific antibody tests
T22	KEYPHRASE-NOTYPES 602 610	early LD
T23	KEYPHRASE-NOTYPES 616 619	IgM
T24	KEYPHRASE-NOTYPES 651 656	weeks
T25	KEYPHRASE-NOTYPES 665 668	IgG
T26	KEYPHRASE-NOTYPES 700 705	weeks
